Hartford Hospital ( Site 0069) — Hartford, Connecticut

Public research footprint of Hartford Hospital ( Site 0069), compiled from the ClinicalTrials.gov public registry.

631

Registered studies

184

Active

Recruiting now

327

Completed

Stopped or withdrawn

Most-studied conditions

Endometrial Clear Cell Adenocarcinoma · Recurrent Fallopian Tube Carcinoma · Recurrent Primary Peritoneal Carcinoma · Recurrent Endometrial Carcinoma

Recently updated registry entries

NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT00977574 — Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or… (Active Not Recruiting)
NCT06901531 — A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hartford Hospital ( Site 0069)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.